<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0058">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Yao</surname>
    <given-names>X.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Li</surname>
    <given-names>G.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Bai</surname>
    <given-names>Q.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Xu</surname>
    <given-names>H.</given-names>
   </name>, &amp; 
   <name name-style="western">
    <surname>Lü</surname>
    <given-names>C.</given-names>
   </name>
  </person-group> (
  <year>2013</year>). 
  <article-title>Taraxerol inhibits LPS-induced inflammatory responses through suppression of TAK1 and Akt activation</article-title>. 
  <source>
   <italic toggle="yes">International Immunopharmacology</italic>
  </source>, (
  <issue>2</issue>), 
  <fpage>316</fpage>–
  <lpage>324</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.intimp.2012.12.032</pub-id>
  <pub-id pub-id-type="pmid">23333629</pub-id>
 </mixed-citation>
</ref>
